ARCHIVES

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

President’s Cancer Panel annual report finds barriers in translational research stall progress.

July 8, 2005

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

NCI Research Project Grant Funding To Exceed $1 Billion In Fiscal 1997

March 14, 1997